Los Angeles Capital Management LLC boosted its stake in Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) by 45.2% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 235,042 shares of the company's stock after acquiring an additional 73,130 shares during the period. Los Angeles Capital Management LLC owned 0.09% of Ryan Specialty worth $15,080,000 as of its most recent SEC filing.
Several other institutional investors have also recently added to or reduced their stakes in the stock. State Street Corp increased its position in Ryan Specialty by 1.5% in the 3rd quarter. State Street Corp now owns 3,273,093 shares of the company's stock valued at $217,301,000 after acquiring an additional 49,198 shares during the period. Janus Henderson Group PLC increased its position in Ryan Specialty by 0.4% in the 3rd quarter. Janus Henderson Group PLC now owns 3,148,916 shares of the company's stock valued at $209,058,000 after acquiring an additional 13,986 shares during the period. Principal Financial Group Inc. increased its position in Ryan Specialty by 115.2% during the 4th quarter. Principal Financial Group Inc. now owns 1,833,209 shares of the company's stock worth $117,619,000 after purchasing an additional 981,505 shares during the period. Barclays PLC increased its position in Ryan Specialty by 1.1% during the 3rd quarter. Barclays PLC now owns 1,641,743 shares of the company's stock worth $108,994,000 after purchasing an additional 17,267 shares during the period. Finally, Eagle Asset Management Inc. increased its position in Ryan Specialty by 32.1% during the 3rd quarter. Eagle Asset Management Inc. now owns 1,380,510 shares of the company's stock worth $98,555,000 after purchasing an additional 335,180 shares during the period. Institutional investors and hedge funds own 84.82% of the company's stock.
Insiders Place Their Bets
In other Ryan Specialty news, Director Nicholas Dominic Cortezi sold 35,000 shares of the stock in a transaction on Friday, December 13th. The stock was sold at an average price of $67.39, for a total transaction of $2,358,650.00. Following the transaction, the director now owns 65,100 shares of the company's stock, valued at $4,387,089. This represents a 34.97 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link. Insiders have sold a total of 316,451 shares of company stock valued at $20,907,793 in the last quarter. 11.10% of the stock is currently owned by company insiders.
Wall Street Analysts Forecast Growth
Several equities analysts have issued reports on RYAN shares. Wells Fargo & Company boosted their target price on Ryan Specialty from $64.00 to $69.00 and gave the stock an "equal weight" rating in a research report on Friday, February 21st. Keefe, Bruyette & Woods dropped their target price on Ryan Specialty from $77.00 to $76.00 and set an "outperform" rating on the stock in a research report on Friday, February 21st. Royal Bank of Canada dropped their target price on Ryan Specialty from $73.00 to $72.00 and set a "sector perform" rating on the stock in a research report on Friday, February 21st. UBS Group boosted their price target on Ryan Specialty from $82.00 to $84.00 and gave the stock a "buy" rating in a research note on Wednesday. Finally, Barclays boosted their price target on Ryan Specialty from $76.00 to $88.00 and gave the stock an "overweight" rating in a research note on Thursday, November 21st. One investment analyst has rated the stock with a sell rating, six have given a hold rating and six have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of "Hold" and a consensus target price of $75.27.
View Our Latest Report on Ryan Specialty
Ryan Specialty Price Performance
RYAN stock traded up $0.04 on Friday, reaching $70.07. The company had a trading volume of 837,569 shares, compared to its average volume of 997,597. Ryan Specialty Holdings, Inc. has a 1 year low of $48.48 and a 1 year high of $75.97. The company has a debt-to-equity ratio of 2.40, a quick ratio of 1.01 and a current ratio of 1.01. The company's fifty day moving average is $66.02 and its 200 day moving average is $67.40. The company has a market cap of $18.35 billion, a P/E ratio of 101.54, a PEG ratio of 1.19 and a beta of 0.72.
Ryan Specialty (NYSE:RYAN - Get Free Report) last posted its earnings results on Thursday, February 20th. The company reported $0.45 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.47 by ($0.02). Ryan Specialty had a net margin of 9.14% and a return on equity of 48.01%. The company had revenue of $663.53 million during the quarter, compared to analysts' expectations of $658.80 million. On average, research analysts forecast that Ryan Specialty Holdings, Inc. will post 2.29 earnings per share for the current year.
Ryan Specialty Increases Dividend
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 18th. Shareholders of record on Tuesday, March 4th will be paid a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a dividend yield of 0.69%. The ex-dividend date is Tuesday, March 4th. This is a positive change from Ryan Specialty's previous quarterly dividend of $0.11. Ryan Specialty's dividend payout ratio is currently 69.57%.
About Ryan Specialty
(
Free Report)
Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.
Featured Articles

Before you consider Ryan Specialty, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ryan Specialty wasn't on the list.
While Ryan Specialty currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report